anticancer peptides examples Anticancer peptides - List ofanticancer peptidesPDF cecropin, magainin, melittin, and buforin II Unveiling the Power of Anticancer Peptides: Examples and Mechanisms

ACPpeptides The fight against cancer is a complex and ongoing battle, with researchers continuously exploring novel therapeutic strategies.Anticancer activities of natural antimicrobial peptides from ... Among the most promising avenues of investigation are anticancer peptides (ACPs). These small molecules, typically composed of 5-30 amino acids, are gaining significant attention for their high selectivity, low toxicity, and multi-target effects, offering a valuable alternative to traditional chemotherapeutics2014年5月26日—The following table contains a list ofpeptides reported to have anti-cancer activitiesagainst solid and hematological tumors.. This article delves into the world of anticancer peptides examples, exploring their diverse origins, mechanisms of action, and the potential they hold for revolutionizing cancer treatment.

What are Anticancer Peptides?

Anticancer peptides are a class of bioactive peptides that exhibit antitumor activity. They are often derived from antimicrobial peptides (AMPs), leveraging their ability to target cell membranes. While AMPs primarily target the cell membranes of microorganisms, ACPs act on cancer cell membranes, a similarity that aids in their development. The amino acid residues that are predominant in peptides with anticancer abilities include glycine, lysine, and leucine, contributing to their specific physicochemical properties and functional roles.

Diverse Origins of Anticancer Peptides

The origins of ACPs are remarkably diverse, spanning across various biological kingdoms and even synthetic design. This broad spectrum of sources contributes to the variety of structures and mechanisms observed.

* Microbial and Insect-Derived Peptides: Many anticancer peptides originate from microbial sources.Bioactive peptides for anticancer therapies - PMC For instance, Alfer is an anticancer microbial peptide obtained from insects and has demonstrated effectiveness against human papillomavirus. Other examples include cecropin A, protegrin-1, and magainin-2, which destabilize cancer cell membranes. Microbial peptides like cecropin, magainin, melittin, and buforin II are considered alpha-ACPs. The human anticancer peptide LL-37 is another notable example, affecting tumor development by inhibiting proteasomes in gastric cancer cells.Exploring the potential of anticancer peptides as... LL-37, defensins, and lactoferricin are among the extensively studied peptides in this category.作者：KY Huang·2021·被引用次数：63—Anticancer peptides(ACPs) are a kind of bioactive peptides which exhibits antitumor activity, which are usually made up of 10 to 100 amino ...

* Plant-Derived Anticancer Peptides (PDACPs): Plant sources are also a rich reservoir for ACPs. Peptides derived from common beans, chickpeas, wheat germ, and mung beans have exhibited antiproliferative and toxic effects on cancer cells. Researchers are exploring the vast potential of Plant-derived anticancer peptides (PDACPs) due to their high specificity, multi-target mechanisms, and favorable safety profiles.Exploring the potential of anticancer peptides as... Over 300 sequences of plant-derived peptides, such as vincristine, paclitaxel, vinblastine, lentinan, camptothecin derivatives, and epipodophyllotoxin, have been identified for their anticancer properties.

* Animal-Derived Peptides: Various animal species contribute to the growing list of ACPs. For example, Bryostatin 1, a well-studied peptide from the bryostatin family, has shown anti-tumour activity. Marine animal species are also a source of unique ACPs.In Silico Models for Designing and Discovering Novel ... Hemiasterlin, hemiasterlin A, and hemiasterlin B are cytotoxic tripeptides isolated from sponge species that act as potential antitumor agents. Furthermore, three novel peptides from Acheta domesticus (crickets) show significant anticancer effects, demonstrating cytotoxicity against liver, breast, and lung cancer cell lines. Similarly, two anticancer oligopeptides (WNHIKRYF, WSVGH) were identified from camel milk protein.

* Synthetic and Hybrid Peptides: Beyond natural sources, scientists are actively designing and modifying peptides to enhance their anticancer efficacy. Hybrid anticancer peptides are engineered to combine beneficial properties, leading to synergistic improvements in cancer therapyBioactive peptides: an alternative therapeutic approach for .... An example of a hybrid peptide is r7-kla (D forms)In Silico Models for Designing and Discovering Novel ....

Mechanisms of Action

Anticancer peptides employ a variety of mechanisms to combat cancer cells, often targeting fundamental cellular processes.

* Membrane Disruption: A common mechanism involves the direct disruption of cancer cell membranes, leading to cell lysis. Peptides like cecropin A, protegrin-1, and magainin-2 are prime examples of ACPs that utilize this method.

* Induction of Apoptosis: Many ACPs can trigger programmed cell death (apoptosis) in cancer cells, effectively eliminating them without harming healthy tissues.

* Immunomodulation: Some anticancer peptides act as immunomodulatory agents, stimulating the body's own immune system to recognize and attack cancer cells. Melittin, Bovine lactoferrin (LfcinB), and Alloferon are examples of peptides with alpha-helical, beta-sheet, and random-coiled structures, respectively, that can exert immunomodulatory effects.

* Targeting Specific Pathways: ACPs can also interfere with specific signaling pathways crucial for cancer cell survival and proliferation作者：C Zhong·2021·被引用次数：35—For example, thehuman anticancer peptide LL-37can affect tumor development by inhibiting proteasome in gastric cancer cells [63, 64]. As .... For example, some peptides can inhibit enzymes or block receptor interactions essential for tumor growth.

* Necrosis Induction: Certain peptides, like Dermaseptin B2, can induce necrosis in cancer cells, characterized by increased lactate dehydrogenase (LDH) release.

Examples of Anticancer Peptides in Research and Therapy

The therapeutic landscape of ACPs is rapidly evolving, with numerous peptides undergoing investigationAnticancer peptides as novel immunomodulatory ....

* Clinical Trials and Pre-clinical Research: Around 13 peptides are currently being investigated for their use in cancer therapeutics, including Tigapotide, SF1126, ATN-161, Teverelix, IRL-1620, and Nelipepimut-S. These peptides have been tested against a wide range of cancer cell lines and tissues.

* Hormone Analogs: In the current market, peptide-based anticancer therapeutics include hormone analogs such as octreotide, leuprolide, and goserelin. These compounds are often linked to cytotoxic agents and targeted to specific tumors possessing corresponding receptors. Similarly, cytotoxic compounds linked to analogs of hormonal peptides like LHRH, bombesin, and somatostatin can be targeted to certain tumors.Best Anti-Cancer Supplements: Ginger, Garlic, and More - Healthline

* Other Notable Examples: Melittin is another example of an anticancer peptide with diverse biological activities. As mentioned earlier, Alfer is an anticancer microbial peptide with demonstrated efficacy. Anticancer peptides such as cecropin, magainin, melittin, and buforin II are recognized for their dual antimicrobial and anticancer potential.

The Future of Anticancer Peptides

The field of anticancer peptides is dynamic, fueled by advancements in artificial intelligence and high-throughput screening. Artificial intelligence-driven anticancer peptide discovery is accelerating the identification and design of novel therapeutic agents. The development of repositories like CancerPPD2 and PeptiHub further aids in curating and annotating this growing body of knowledge2012年12月20日—Cytotoxic compounds linked to analogs of hormonal peptides likeLHRH, bombesin, and somatostatincan be targeted to certain tumors possessing ....

Peptide-based drugs offer a promising future in cancer therapy due to their specificity, lower toxicity, and ease of synthesis compared to conventional treatments. As research progresses, we can expect to see more peptides reported to have anti-cancer activities translated into effective clinical applications, offering new hope in the fight against various types of cancers, including solid tumors and hematological malignancies. The ongoing exploration of examples of anticancer peptides underscores their significant potential to transform cancer treatment paradigms.